BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12052041)

  • 1. Endocannabinoids and basal ganglia functionality.
    Fernández-Ruiz J; Lastres-Becker I; Cabranes A; González S; Ramos JA
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):257-67. PubMed ID: 12052041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid receptors and their ligands.
    Pertwee RG; Ross RA
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):101-21. PubMed ID: 12052030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy.
    Rice AS; Farquhar-Smith WP; Nagy I
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):243-56. PubMed ID: 12052040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoids in pain modulation.
    Walker JM; Huang SM
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):235-42. PubMed ID: 12052039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid control of motor function at the basal ganglia.
    Fernández-Ruiz J; Gonzáles S
    Handb Exp Pharmacol; 2005; (168):479-507. PubMed ID: 16596785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoids in the immune system and cancer.
    Parolaro D; Massi P; Rubino T; Monti E
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):319-32. PubMed ID: 12052046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects.
    Romero J; Lastres-Becker I; de Miguel R; Berrendero F; Ramos JA; Fernández-Ruiz J
    Pharmacol Ther; 2002 Aug; 95(2):137-52. PubMed ID: 12182961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endocannabinoid system in invertebrates.
    Salzet M; Stefano GB
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):353-61. PubMed ID: 12052049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CB(1) and CB(2) receptor-mediated signalling: a focus on endocannabinoids.
    McAllister SD; Glass M
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):161-71. PubMed ID: 12052033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoids in cognition and dependence.
    Lichtman AH; Varvel SA; Martin BR
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):269-85. PubMed ID: 12052042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of endocannabinoids in the hypothalamic regulation of visceral function.
    Wenger T; Moldrich G
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):301-7. PubMed ID: 12052044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal cannabinoid CB1 receptor mRNA expression is decreased in the reserpine-treated rat model of Parkinson's disease.
    Silverdale MA; McGuire S; McInnes A; Crossman AR; Brotchie JM
    Exp Neurol; 2001 Jun; 169(2):400-6. PubMed ID: 11358453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.
    Burns TL; Ineck JR
    Ann Pharmacother; 2006 Feb; 40(2):251-60. PubMed ID: 16449552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview.
    Basavarajappa BS; Hungund BL
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):287-99. PubMed ID: 12052043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endogenous cannabinoids in synaptic signaling.
    Freund TF; Katona I; Piomelli D
    Physiol Rev; 2003 Jul; 83(3):1017-66. PubMed ID: 12843414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoids in the new millennium.
    Di Marzo V
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):91-2. PubMed ID: 12052028
    [No Abstract]   [Full Text] [Related]  

  • 17. The endocannabinoid system as a target for the treatment of motor dysfunction.
    Fernández-Ruiz J
    Br J Pharmacol; 2009 Apr; 156(7):1029-40. PubMed ID: 19220290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
    Smith PF
    Curr Opin Investig Drugs; 2002 Jun; 3(6):859-64. PubMed ID: 12137404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic neuroanatomy and neuropharmacology of cannabinoids.
    Breivogel CS; Sim-Selley LJ
    Int Rev Psychiatry; 2009 Apr; 21(2):113-21. PubMed ID: 19367505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoid-mediated control of synaptic transmission.
    Kano M; Ohno-Shosaku T; Hashimotodani Y; Uchigashima M; Watanabe M
    Physiol Rev; 2009 Jan; 89(1):309-80. PubMed ID: 19126760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.